Recent Comments

Comment RSS

Stem Cell News and Research RSS Feed - Stem Cell News and Research

Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive. When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

Stem cells are distinguished from other cell types by two important characteristics. First, they are unspecialized cells capable of renewing themselves through cell division, sometimes after long periods of inactivity. Second, under certain physiologic or experimental conditions, they can be induced to become tissue- or organ-specific cells with special functions. In some organs, such as the gut and bone marrow, stem cells regularly divide to repair and replace worn out or damaged tissues. In other organs, however, such as the pancreas and the heart, stem cells only divide under special conditions.

SCF founder Sabrina Cohen recognized as a WebMD 2009 Health Hero

20. November 2009 08:04
Sabrina Cohen, founder of The Sabrina Cohen Foundation for Stem Cell Research (SCF), was just recognized as a WebMD 2009 Health Hero. She will receive national media attention with a full-page article about her personal story of triumph and courage, and shares the spotlight with celebrity movie-star, Scarlett Johansson and other Health Heroes in the November/December issue. [More]

Posted in: Medical Science News | Miscellaneous News

Tags: , , , , , , ,

Review of R&D and novel therapeutic challenges in neurological disorders

20. November 2009 04:39
Research and Markets (http://www.researchandmarkets.com/research/fae4d4/neurological_disea) has announced the addition of Decision Resources, Inc.'s new report "Neurological Disease: Early-Stage R&D and Dealmaking" to their offering. [More]

I-STEM team succeeds in recreating a whole epidermis from hES cells

20. November 2009 03:07
Stem cell research is making great strides. This is yet again illustrated by a study carried out by the I-STEM Institute (I-STEM/ Inserm UEVE U861/AFM), published in the Lancet on 21 November 2009. The I-STEM team, directed by Marc Peschanski has just succeeded in recreating a whole epidermis from human embryonic stem cells. [More]

Posted in: Medical Science News

Tags: , , , ,

Comprehensive report on world cancer therapies market

20. November 2009 01:37
Research and Markets (http://www.researchandmarkets.com/research/4b82d8/cancer_therapies) has announced the addition of the "Cancer Therapies - Global Market Opportunities" report to their offering. [More]

Advanced Cell Technology files an IND with the FDA for study using embryonic stem cells to treat SMD

19. November 2009 10:45
Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt’s Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina. [More]

WaferGen Biosystems launches new SmartChip Service for gene-expression profiling of thousands of genes

19. November 2009 09:18
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, today announced a new, innovative service for gene-expression profiling of thousands of genes using the SmartChip(TM) Real-Time PCR System. By taking advantage of the SmartChip Real-Time PCR system, WaferGen will offer universities, pharmaceutical and diagnostic companies a service that utilizes pathway-specific gene panels to discover and validate new biomarkers. [More]

Posted in: Medical Science News

Tags: , , , , , ,

ISCO, Scripps Research Institute collaborate in study of parthenogenetic stem cells

19. November 2009 08:23
International Stem Cell Corporation, announced today that it is collaborating with renowned stem cell researcher Jeanne F. Loring, Ph.D., and the Scripps Research Institute (La Jolla, CA) to study parthenogenetic stem cells and potentially therapeutic cells that can be derived from them. [More]

Posted in: Medical Science News

Tags: , , , ,

NanoString Technologies to investigate molecular networks with the Broad Institute of MIT and Harvard

19. November 2009 06:13
NanoString Technologies, Inc., a privately held life sciences company marketing a molecular barcoding detection system, today announced that it is collaborating with the Broad Institute of MIT and Harvard to investigate molecular networks involved in immune response and other important biological processes. [More]

Posted in: Business / Finance | Medical Science News

Tags: , , ,

BIMR wins a GO grant from the National Institute of Mental Health

19. November 2009 04:06
Thanks to a $50,000 grant from the California Bipolar Foundation (CBF) to post-doctoral research fellow Dr. Illyas Singec at the Burnham Institute for Medical Research (BIMR), a research team headed by Dr. Evan Snyder (along with co-investigators Drs. Dieter Wolfe and Lawrence Brill), was able to accumulate sufficient preliminary data to win an extremely competitive Grand Opportunities (GO) grant from the National Institute of Mental Health to explore the molecular basis of Bipolar Disorder (BPD). [More]

Posted in: Medical Science News | Medical Condition News

Tags: , , , , , ,

CEL-SCI commences clinical study of LEAPS-H1N1 treatment for hospitalized patients

18. November 2009 11:14
CEL-SCI Corporation, a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today the start of the Company's first clinical study for hospitalized H1N1 patients at The Johns Hopkins University School of Medicine (Johns Hopkins). [More]

Minimally invasive procedures drive the global uro-gynecological surgical devices market

18. November 2009 07:50
World uro-gynecological surgical devices market is driven by the growing acceptance of minimally invasive procedures as a convenient alternative option to hysterectomy. [More]

Gene that tells embryonic stem cells when to stop producing neurons identified

18. November 2009 07:00
Researchers from North Carolina State University have identified a gene that tells embryonic stem cells in the brain when to stop producing nerve cells called neurons. The research is a significant advance in understanding the development of the nervous system, which is essential to addressing conditions such as Parkinson's disease, Alzheimer's disease and other neurological disorders. [More]

VINNOVA to provide SEK 3.6 million for Vitrolife’s stem-cell research

18. November 2009 06:57
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife’s research project for optimized culture media to enable the clinical use of stem cells. “It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future”, says Magnus Nilsson, Vitrolife’s CEO. [More]

Posted in: Medical Science News

Tags: , , , , , ,

Overview of current CML therapies

18. November 2009 05:59
Research and Markets (http://www.researchandmarkets.com/research/44c77e/chronic_myelogenou) has announced the addition of Decision Resources, Inc.'s new report "Chronic Myelogenous Leukemia: New Targeted Therapies Take Aim at Gleevec" to their offering. [More]

Posted in: Device / Technology News

Tags: , , , , , , , , ,

Gene therapy may hold promise for cryptorchid individuals risking infertility

18. November 2009 05:47
EGR4 is a master gene responsible for fertility in cryptorchidism. Is gene therapy going to replace surgery? [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.